<table id="_RefID0EDVAE" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Select Mean (±S.D.) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin</caption>
<col width="36%"></col>
<col width="14%"></col>
<col width="14%"></col>
<col width="13%"></col>
<thead>
<tr>
<th align="left" stylecode="Toprule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="center" stylecode="Toprule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="center" stylecode="Toprule " valign="top">
<content stylecode="bold"> </content>
</th>
<th align="center" stylecode="Toprule " valign="top">
<content stylecode="bold"> Renal</content>
</th>
</tr>
<tr>
<th align="left" valign="top">
<content stylecode="bold"> Subject Groups: Metformin </content>
</th>
<th align="center" valign="top">
<content stylecode="bold"> C<sub>max</sub>
<sup>b</sup>
</content>
</th>
<th align="center" valign="top">
<content stylecode="bold"> T<sub>max</sub>
<sup>c</sup>
</content>
</th>
<th align="center" valign="top">
<content stylecode="bold"> Clearance</content>
</th>
</tr>
<tr>
<th align="left" stylecode="Botrule " valign="top">
<content stylecode="bold"> Dose<sup>a</sup> (number of subjects)</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold"> (μg/mL)</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold"> (hrs)</content>
</th>
<th align="center" stylecode="Botrule " valign="top">
<content stylecode="bold"> (mL/min)</content>
</th>
</tr>
</thead>
<tfoot>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>a</sup>All doses given fasting except the first 18 doses of the multiple-dose studies</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>b</sup>Peak plasma concentration</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>c</sup>Time to peak plasma concentration</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>d</sup>SD = single dose</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>e</sup>Combined results (average means) of five studies: mean age 32 years (range 23-59 years)</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>f</sup>Kinetic study done following dose 19, given fasting</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>g</sup>Elderly subjects, mean age 71 years (range 65-81 years)</td>
</tr>
<tr>
<td align="left" colspan="4" stylecode="Botrule" valign="top"> <sup>h</sup>CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
</td>
</tr>
</tfoot>
<tbody>
<tr>
<td stylecode="Toprule ">
<paragraph> Healthy, nondiabetic Adults:</paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph> </paragraph>
</td>
<td align="center" stylecode="Toprule ">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> 500 mg SD<sup>d </sup>(24)</paragraph>
</td>
<td align="center">
<paragraph> 1.03 (±0.33)</paragraph>
</td>
<td align="center">
<paragraph> 2.75 (±0.81)</paragraph>
</td>
<td align="center">
<paragraph> 600 (±132)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> 850 mg SD (74)<sup>e</sup>
</paragraph>
</td>
<td align="center">
<paragraph> 1.60 (±0.38)</paragraph>
</td>
<td align="center">
<paragraph> 2.64(±0.82)</paragraph>
</td>
<td align="center">
<paragraph> 552 (±139)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> 850 mg t.i.d. for 19 doses<sup>f</sup> (9)</paragraph>
</td>
<td align="center">
<paragraph> 2.01 (±0.42)</paragraph>
</td>
<td align="center">
<paragraph> 1.79(±0.94)</paragraph>
</td>
<td align="center">
<paragraph> 642 (±173)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Adults with type 2 diabetes: </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> 850 mg SD (23)</paragraph>
</td>
<td align="center">
<paragraph> 1.48 (±0.5)</paragraph>
</td>
<td align="center">
<paragraph> 3.32 (±1.08)</paragraph>
</td>
<td align="center">
<paragraph> 491 (±138)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> 850 mg t.i.d. for 19 doses<sup>f</sup> (9)</paragraph>
</td>
<td align="center">
<paragraph> 1.90 (±0.62)</paragraph>
</td>
<td align="center">
<paragraph> 2.01 (±1.22)</paragraph>
</td>
<td align="center">
<paragraph> 550 (±160)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Elderly<sup>g</sup>, healthy nondiabetic adults: </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> 850 mg SD (12)</paragraph>
</td>
<td align="center">
<paragraph> 2.45 (±0.70)</paragraph>
</td>
<td align="center">
<paragraph> 2.71 (±1.05)</paragraph>
</td>
<td align="center">
<paragraph> 412 (±98)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Renal-impaired adults:</paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> 850 mg SD</paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
<td align="center">
<paragraph> </paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Mild (CL<sub>cr</sub>
<sup>h</sup> 61-90 mL/min) (5)</paragraph>
</td>
<td align="center">
<paragraph> 1.86 (±0.52)</paragraph>
</td>
<td align="center">
<paragraph> 3.20 (±0.45)</paragraph>
</td>
<td align="center">
<paragraph> 384 (±122)</paragraph>
</td>
</tr>
<tr>
<td>
<paragraph> Moderate (CL<sub>cr</sub> 31-60 mL/min) (4)</paragraph>
</td>
<td align="center">
<paragraph> 4.12 (±1.83)</paragraph>
</td>
<td align="center">
<paragraph> 3.75 (±0.50)</paragraph>
</td>
<td align="center">
<paragraph> 108 (±57)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Botrule ">
<paragraph> Severe (CL<sub>cr</sub> 10-30 mL/min) (6)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph> 3.93 (±0.92)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph> 4.01 (±1.10)</paragraph>
</td>
<td align="center" stylecode="Botrule ">
<paragraph> 130 (±90)</paragraph>
</td>
</tr>
</tbody>
</table>